Invalid Symbol

Stock Research for MRTX

MRTX
Current Price

$


Latest Update:

High
$
Low
$
Close
$
Volume
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

MRTX Stock Chart & Research Data

The MRTX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MRTX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


MRTX Due diligence Resources & Stock Charts

The MRTX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View MRTX Detailed Price Forecast - CNN Money CNN View MRTX Detailed Summary - Google Finance
Yahoo View MRTX Detailed Summary - Yahoo! Finance Zacks View MRTX Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View MRTX Trends & Analysis - Trade-Ideas Barrons View MRTX Major Holders - Barrons
NASDAQ View MRTX Call Transcripts - NASDAQ Seeking View MRTX Breaking News & Analysis - Seeking Alpha
Spotlight View MRTX Annual Report - CompanySpotlight.com OTC Report View MRTX OTC Short Report - OTCShortReport.com
TradeKing View MRTX Fundamentals - TradeKing Charts View MRTX SEC Filings - Bar Chart
WSJ View Historical Prices for MRTX - The WSJ Morningstar View Performance/Total Return for MRTX - Morningstar
MarketWatch View the Analyst Estimates for MRTX - MarketWatch CNBC View the Earnings History for MRTX - CNBC
StockMarketWatch View the MRTX Earnings - StockMarketWatch MacroAxis View MRTX Buy or Sell Recommendations - MacroAxis
Bullish View the MRTX Bullish Patterns - American Bulls Short Pains View MRTX Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View MRTX Stock Mentions - StockTwits PennyStocks View MRTX Stock Mentions - PennyStockTweets
Twitter View MRTX Stock Mentions - Twitter Invest Hub View MRTX Investment Forum News - Investor Hub
Yahoo View MRTX Stock Mentions - Yahoo! Message Board Seeking Alpha View MRTX Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for MRTX - SECform4.com Insider Cow View Insider Transactions for MRTX - Insider Cow
CNBC View MRTX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for MRTX - OTC Markets
Yahoo View Insider Transactions for MRTX - Yahoo! Finance NASDAQ View Institutional Holdings for MRTX - NASDAQ


Stock Charts

FinViz View MRTX Stock Insight & Charts - FinViz.com StockCharts View MRTX Investment Charts - StockCharts.com
BarChart View MRTX Stock Overview & Charts - BarChart Trading View View MRTX User Generated Charts - Trading View


Latest Financial News for MRTX

Mirati Therapeutics To Present At Leerink Partners 7th Annual Global Healthcare Conference
Posted on Thursday February 08, 2018

SAN DIEGO , Feb. 8, 2018 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical stage targeted oncology biotechnology company, will participate in the Leerink Partners 7 th Annual Global ...


Nektar Notches New Highs As Stock Triples In Two Months
Posted on Thursday January 11, 2018

Biotech and pharma stocks dominate our list of top charts to watch today.


Harry Boxer’s three health-care stocks to watch today
Posted on Wednesday January 10, 2018

In focus: Collegium Pharmaceutical, Mirati Therapeutics and Nektar Therapeutics.


BeiGene and Mirati Therapeutics Announce Exclusive License Agreement for Sitravatinib in the Asia Pacific Region
Posted on Monday January 08, 2018

CAMBRIDGE, Mass. and BEIJING, China and SAN DIEGO, Jan. 08, 2018-- BeiGene, Ltd., a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted ...


Mirati Therapeutics: Buy The Dip
Seeking Alpha - Nov 15, 2017
At one point shares rose by as much as 45% since my initial article in September. I believe today´s dip represents a buying opportunity.
Mirati Therapeutics (MRTX) Prices 2M Offering of Common Stock at $13/Share - StreetInsider.com

Mirati Therapeutics: Double Could Be Just The Beginning
Seeking Alpha - Sep 18, 2017
While some might believe the jump was an overreaction due to low patient numbers, I believe it's just the start of a bigger, long-term movement.
A Peek Into The Future For Mirati Therapeutics - Benzinga
UPDATE: Mirati Therapeutics, Inc. (MRTX) PT Raised to $16 at Citi - StreetInsider.com

Mirati Therapeutics: Is This $5 Busted IPO A Buy, Sell, Or Hold?
Seeking Alpha - Jul 31, 2017
Company Overview: With a market capitalization of just $120 million, Mirati Therapeutics (MRTX) and its shareholders have weathered a couple rough years.

Mirati Therapeutics Announces Advancement Of First-In-Class Opportunities With ...
PR Newswire (press release) - Nov 13, 2017
SAN DIEGO, Nov. 13, 2017 /PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX) (the Company or Mirati), a clinical-stage targeted oncology company, today announced that it is reprioritizing its development programs to capitalize on encouraging data ...

Enter a stock symbol to view the stock details.